metastatic renal cell cancer

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cryosurgery
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 6, 2022

Metastatic Renal Cell Cancer Trial in United States (Axitinib)

Active, not recruiting
  • Metastatic Renal Cell Cancer
  • Duarte, California
  • +3 more
Jun 1, 2022

Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body

Recruiting
  • Metastatic Renal Cell Cancer
  • +2 more
  • Stereotactic Body Radiation Therapy
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 3, 2022

Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

Completed
  • Metastatic Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 8, 2022

Predict Treatment Efficacy in Renal Cell Carcinoma

Completed
  • Metastatic Renal Cell Cancer
  • perfusion computed tomography
  • Stanford, California
    Stanford University Cancer Institute
Jan 31, 2022

Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)

Active, not recruiting
  • Kidney Neoplasms
  • Metastatic Renal Cell Cancer
  • Besancon, Franche-ComtĂ©, France
    CHU Besancon
Nov 17, 2021

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic Trial in Meldola (FC) (Boost of radiotherapy + high dose IL-2

Recruiting
  • Metastatic Renal Cell Cancer
  • Malignant Melanoma, Metastatic
  • Boost of radiotherapy + high dose IL-2 treatment
  • Meldola (FC), FC, Italy
    UO Oncologia Medica, IRCCS IRST
Feb 25, 2021

Metastatic Renal Cell Cancer Trial in France (Pazopanib, Sunitinib)

Completed
  • Metastatic Renal Cell Cancer
  • Bordeaux, France
  • +7 more
Jan 11, 2021

Metastatic Renal Cell Cancer Trial in United States (RX-0201)

Terminated
  • Metastatic Renal Cell Cancer
  • Tucson, Arizona
  • +6 more
Jun 15, 2020

Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +29 more
  • Fludarabine Phosphate
  • +5 more
  • Tucson, Arizona
  • +9 more
Dec 18, 2019

Metastatic Melanoma, Metastatic Renal Cell Cancer, Metastatic Cancer Trial run by the NCI (Anti-NY ESO-1 T-cell receptor PBL,

Terminated
  • Metastatic Melanoma
  • +2 more
  • Anti-NY ESO-1 T-cell receptor PBL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 6, 2019

Metastatic Renal Cell Cancer Trial in Guangzhou (Cryosurgery, NK immunotherapy)

Completed
  • Metastatic Renal Cell Cancer
  • Cryosurgery
  • NK immunotherapy
  • Guangzhou, Guangdong, China
    Cancer Institute in Fuda cancer hospital
Sep 10, 2019

Metastatic Renal Cell Cancer Trial in Canada, United States (Drug: LY573636-sodium, Sunitinib)

Completed
  • Metastatic Renal Cell Cancer
  • Indianapolis, Indiana
  • +4 more
Dec 16, 2018

Advanced or Metastatic Hepatocellular Cancer, Advanced or Metastatic Ovarian Cancer, Metastatic Renal Cell Cancer Trial in

Completed
  • Advanced or Metastatic Hepatocellular Cancer
  • +3 more
  • Edegem, Belgium
  • +23 more
Jan 4, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Renal Cell Cancer, Metastatic Renal Cell Cancer Trial in Beijing (Famitinib, Sunitinib)

Completed
  • Renal Cell Cancer
  • Metastatic Renal Cell Cancer
  • Beijing, China
    Cancer Institute and Hospital Chinese Academy of Medical Science
May 1, 2018

Metastatic Renal Cell Cancer Trial in Netherlands (Everolimus)

Completed
  • Metastatic Renal Cell Cancer
  • Alkmaar, Netherlands
  • +12 more
May 9, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Cognitive Function of Patients With Sunitinib or Sorafenib

Completed
  • Metastatic Renal Cell Cancer
  • GIST
    • Nijmegen, Gelderland, Netherlands
      University Medical Centre Nijmegen
    Nov 1, 2011

    Metastatic Renal Cell Cancer Trial in Worldwide (Everolimus)

    No longer available
    • Metastatic Renal Cell Cancer
    • Springdale, Arkansas
    • +84 more
    Aug 18, 2011